Work

Supplementary Table S1 from Characteristics of a CCL21 Gene–Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non–Small Cell Lung Cancer

Year: 2025
Type: supplementary-materials
Abstract: Supplementary Table S1. Marker genes for DC subsets determined by scRNA-seq.
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4407146248
Cites:
Cited by:
Related to: 10